Vertex Initiates Second Phase 3 VX-659 Triple Combination Study in Certain People with Cystic Fibrosis

Fueled by the needs of patients, families, doctors and nurses, our CF “Translators” share their thoughts and stories about what motivates them to take part in the relentless pursuit of fighting for a cure

"Diversity matters to our business, it matters to our culture and it’s who we want to be as an organization."

The Stories Behind Vertex: 

@vertexpharma